State Street Corp Enanta Pharmaceuticals Inc Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 449,975 shares of ENTA stock, worth $4.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
449,975
Previous 422,828 6.42%
Holding current value
$4.09 Million
Previous $5.48 Million 14.92%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.05 - $16.54 $272,827 - $449,011
27,147 Added 6.42%
449,975 $4.67 Million
Q2 2024

Aug 14, 2024
SELL
$11.43 - $17.02 $12,995 - $19,351
-1,137 Reduced 0.27%
422,828 $5.48 Million
Q1 2024

May 15, 2024
SELL
$10.08 - $17.46 $16,884 - $29,245
-1,675 Reduced 0.39%
423,965 $7.4 Million
Q4 2023

Feb 14, 2024
SELL
$8.18 - $10.78 $200,557 - $264,304
-24,518 Reduced 5.45%
425,640 $4.01 Million
Q3 2023

Nov 14, 2023
SELL
$11.09 - $22.13 $11.8 Million - $23.6 Million
-1,068,093 Reduced 70.35%
450,158 $5.03 Million
Q2 2023

Aug 14, 2023
BUY
$20.68 - $39.85 $6.56 Million - $12.6 Million
317,315 Added 26.42%
1,518,251 $32.5 Million
Q1 2023

May 15, 2023
SELL
$38.82 - $54.59 $12.1 Million - $17 Million
-311,256 Reduced 20.58%
1,200,936 $48.6 Million
Q4 2022

Feb 14, 2023
BUY
$40.77 - $53.73 $5.49 Million - $7.24 Million
134,775 Added 9.78%
1,512,192 $70.3 Million
Q3 2022

Nov 15, 2022
SELL
$48.29 - $71.27 $15.5 Million - $22.9 Million
-322,011 Reduced 18.95%
1,377,417 $71.4 Million
Q2 2022

Aug 15, 2022
BUY
$38.13 - $76.93 $14.9 Million - $30.1 Million
390,842 Added 29.87%
1,699,428 $80.3 Million
Q1 2022

May 16, 2022
BUY
$56.06 - $74.11 $10.2 Million - $13.5 Million
181,517 Added 16.11%
1,308,586 $93.1 Million
Q4 2021

Feb 14, 2022
BUY
$60.19 - $97.37 $3.3 Million - $5.34 Million
54,887 Added 5.12%
1,127,069 $84.3 Million
Q3 2021

Nov 15, 2021
BUY
$41.02 - $58.65 $742,749 - $1.06 Million
18,107 Added 1.72%
1,072,182 $60.9 Million
Q2 2021

Aug 16, 2021
SELL
$43.76 - $53.11 $1.93 Million - $2.34 Million
-44,049 Reduced 4.01%
1,054,075 $46.4 Million
Q1 2021

May 17, 2021
SELL
$41.69 - $54.95 $3.13 Million - $4.13 Million
-75,116 Reduced 6.4%
1,098,124 $54.2 Million
Q4 2020

Feb 16, 2021
BUY
$41.16 - $47.47 $8.63 Million - $9.96 Million
209,722 Added 21.77%
1,173,240 $49.4 Million
Q3 2020

Nov 10, 2020
SELL
$43.36 - $53.53 $4.14 Million - $5.12 Million
-95,578 Reduced 9.02%
963,518 $44.1 Million
Q2 2020

Aug 14, 2020
BUY
$46.37 - $57.58 $7.01 Million - $8.7 Million
151,172 Added 16.65%
1,059,096 $53.2 Million
Q1 2020

May 11, 2020
BUY
$40.22 - $62.0 $36.5 Million - $56.3 Million
907,924 New
907,924 $46.7 Million

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $188M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email